Australia is a world leader in pharmaceutical industry conduct, and will continue to work towards further transparency of industry’s interactions with health care professionals, pharma trade group Medicines Australia’s chief executive Brendan Shaw said last week.
Responding to the implementation of the new expanded International Federation of Pharmaceutical Manufacturers and Associations’ Code of Practice, Dr Shaw said Australian consumers can be confident that the standards of ethical conduct and transparency demanded by the Medicines Australia Code of Conduct far exceed those of other countries.
“The expanded global Code is a positive step forward. It articulates high-level principles that hold companies to a high standard of ethical conduct,” Dr Shaw said, adding: “It also imposes new requirements that have been in place in Australia for many years, such as banning personal gifts and the provision of entertainment at educational events.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze